14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:FPRX
Delisted

Five Prime Therapeutics Stock Price (Quote)

$38.00
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.00 $38.00 Friday, 27th May 2022 FPRX stock ended at $38.00. During the day the stock fluctuated 0% from a day low at $38.00 to a day high of $38.00.
90 days $38.00 $38.00
52 weeks $38.00 $38.00

Historical Five Prime Therapeutics prices

Date Open High Low Close Volume
Feb 09, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 08, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 07, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 04, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 03, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 02, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 01, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 31, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 28, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 27, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 26, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 25, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 24, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 21, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 20, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 19, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 18, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 14, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 13, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 12, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 11, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 10, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 07, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 06, 2022 $38.00 $38.00 $38.00 $38.00 0
Jan 05, 2022 $38.00 $38.00 $38.00 $38.00 0
Click to get the best stock tips daily for free!

About Five Prime Therapeutics

Five Prime Therapeutics Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes in the United States. The company’s product candidates include FPA008, an antibody that inhibits colony stimulating factor-1 receptor and is in Phase Ia/Ib clinical trials for the treatment of various cancers in combination with nivolumab; and is in Phase I/II... FPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT